In many ways, the next ten years promise to be the single brightest decade the pharmaceutical world has ever seen, and we are speaking about an industry that has gone from strength to strength for most of its history. Not only are Small Molecule products undergoing a renaissance powered in part by Digital Transformation while Large Molecule products are finally enjoying their first Golden Age as a now established and mature biopharmaceutical sector within the larger whole, but a whole new and novel generation of products is at last reaching the tipping point of commercialization and stands at the cusp…